Pharmadrug Inc.
PHRX
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 81.06% | 100.58% | 40.68% | 66.35% | -178.82% |
| Total Depreciation and Amortization | -5.38% | -53.37% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -29.89% | -100.46% | 31.37% | -10.84% | 255.65% |
| Change in Net Operating Assets | 132.08% | -237.32% | -19.17% | -251.59% | -206.26% |
| Cash from Operations | 97.42% | 100.47% | 94.09% | -54.55% | -491.35% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -4,200.00% | -- | -- | -- |
| Cash from Investing | -- | -101.58% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 270.65% | -- | -- | -- |
| Cash from Financing | -- | 91.49% | -- | -- | 380.51% |
| Foreign Exchange rate Adjustments | -- | -383.33% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.56% | -104.22% | -106.25% | -12,566.67% | -161,400.00% |